Archives of Medical Research
Volume 40, Issue 7 , Pages 590-594 , October 2009

Elevated Circulating and Synovial Fluid Endoglin Are Associated with Primary Knee Osteoarthritis Severity

  • Sittisak Honsawek

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    • Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    • Corresponding Author InformationAddress reprint request to: Sittisak Honsawek, M.D., Ph.D., Department of Biochemistry and Orthopaedics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Rama IV road, Patumwan, Bangkok 10330, Thailand; Phone: +662-256-4482; FAX: +662-256-4482
    • ,
  • Aree Tanavalee

      Affiliations

    • Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    • ,
  • Pongsak Yuktanandana

      Affiliations

    • Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Received 16 April 2009 ,Accepted 10 July 2009.

References 

  1. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44:1237–1247
  2. Krasnokutsky S, Attur M, Palmer G, et al. Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage. 2008;16(suppl):1–3
  3. Westphal JR, Willems HW, Schalkwijk CJ, et al. A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. J Invest Dermatol. 1993;100:27–34
  4. Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer. 1999;81:568–572
  5. Torsney E, Charlton R, Parums D, et al. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res. 2002;51:464–470
  6. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999;274:584–594
  7. Li C, Hampson IN, Hampson L, et al. CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J. 2000;14:55–64
  8. Parker WL, Goldring MB, Philip A. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGF beta receptor independent manner. J Bone Miner Res. 2003;18:289–302
  9. Szekanecz Z, Haines GK, Harlow LA, et al. Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol. 1995;76:187–194
  10. Honsawek S, Chayanupatkul M, Tanavalee A, et al. Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop. 2009;33:1171–1175
  11. Honsawek S, Tanavalee A, Sakdinakiattikoon M, et al. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem. 2009;42:808–812
  12. Pilichou A, Papassotiriou I, Michalakakou K, et al. High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem. 2008;41:746–749
  13. Pagura SM, Thomas SG, Woodhouse LJ, et al. Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men. J Orthop Res. 2005;23:397–405
  14. Kaneko S, Satoh T, Chiba J, et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther. 2000;6:71–79
  15. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502
  16. Massagué J, Attisano SL, Wrana SL. The TGF-β family and its composite receptors. Trends Cell Biol. 1994;4:172–178
  17. Cheifetz S, Bellón T, Calés C, et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem. 1992;267:19027–19030
  18. Letamendía A, Lastres P, Botella LM, et al. Role of endoglin in cellular responses to transforming growth factor-β: a comparative study with betaglycan. J Biol Chem. 1998;273:33011–33019
  19. Gougos A, St Jacques S, Greaves A, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol. 1992;4:83–92
  20. Park MC, Chung SJ, Park YB, et al. Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis. Clin Exp Rheumatol. 2008;26:881–886
  21. Scola MP, Imagawa T, Boivin GP, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum. 2001;44:794–801
  22. van Laake LW, van den Driesche S, Post S, et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation. 2006;114:2288–2297

PII: S0188-4409(09)00136-2

doi: 10.1016/j.arcmed.2009.07.010

Archives of Medical Research
Volume 40, Issue 7 , Pages 590-594 , October 2009

Article Tools

* Image Usage & Resolution